P1119: the oral pi3kδ inhibitor linperlisib for the treatment of relapsed or refractory follicular lymphoma: a single-arm multicenter phase 2 clinical trial
HemaSphere(2022)
关键词
oral pi3kδ inhibitor linperlisib,refractory follicular lymphoma,single-arm
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要